Abbott Laboratories
ABT Healthcare Medical Devices
Abbott Laboratories' revenue for fiscal 2025 (year ended December 2025) was $44.3 billion, up 5.67% from fiscal 2024. In the quarter to June 2026, revenue grew 13.0%, EPS fell 47.5%, free cash flow grew 28.9% and total debt rose 142.7%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years; insiders bought in the last twelve months.
Follow ABT
Abbott Laboratories (ABT) P/E ratio
As of 16 October 2026, Abbott Laboratories (ABT) trades at a P/E ratio of 33.9×. Over the past ten years it has ranged from 12.4× (February 2016) to 254× (June 2018); the current reading is higher than 48% of that period. That is above the Medical Devices industry median of 23.2× and above the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 33.7× | 127.79% |
| FY2024 | 14.8× | (56.12%) |
| FY2023 | 33.7× | 20.23% |
| FY2022 | 28.0× | (21.54%) |
| FY2021 | 35.7× | (18.44%) |
| FY2020 | 43.8× | 3.87% |
| FY2019 | 42.2× | (22.47%) |
| FY2018 | 54.4× | (75.95%) |
| FY2017 | 226× | 438.51% |
| FY2016 | 42.0× | 173.01% |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 29.4× | 2.11% |
| Mar 2026 | 28.8× | (14.61%) |
| Dec 2025 | 33.7× | 100.66% |
| Sep 2025 | 16.8× | (1.52%) |
| 42 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| GEHC GE HealthCare Technologies Inc. compare | 16.0× |
| BSX Boston Scientific Corporation compare | 17.9× |
| PHG Koninklijke Philips N.V. compare | 18.8× |
| MDT Medtronic PLC compare | 23.2× |
| STE STERIS plc compare | 27.1× |
| SYK Stryker Corporation compare | 30.3× |
| DXCM DexCom, Inc. compare | 33.2× |
| ABT Abbott Laboratories | 33.9× |
| EW Edwards Lifesciences Corporation compare | 49.8× |
| Medical Devices industry median | 23.2× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on ABT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement